Robert Micheal Gauthier

US Patent:

20130200486, Aug 8, 2013

Filed:

Mar 15, 2013

Appl. No.:

13/835463

Inventors:

International Business Machines Corporation - Armonk NY, US
Jason E. Cummings - Albany NY, US
Toshiharu Furukawa - Essex Junction VT, US
Robert J. Gauthier - Hinesburg VT, US
Jed H. Rankin - Richmond VT, US
Robert R. Robison - Colchester VT, US
William R. Tonti - Essex Junction VT, US

Assignee:

International Business Machines Corporation - Armonk NY

International Classification:

H01L 29/06

US Classification:

257507

Abstract:

Various aspects include extremely thin semiconductor-on-insulator (ETSOI) layers. In one embodiment, an ETSOI layer includes a plurality of shallow trench isolations (STI) defining a plurality of distinct semiconductor-on-insulator (SOI) regions, the distinct SOI regions having at least three different thicknesses; at least one recess located within the distinct SOI regions; and an oxide cap over the at least one recess.

US Patent:

49766830, Dec 11, 1990

Filed:

Jul 18, 1988

Appl. No.:

7/220779

Inventors:

Robert J. Gauthier - Lake Forest IL
Robert S. Levinson - Saline MI

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61M 100

US Classification:

604 29

Abstract:

This invention relates to an improved method for conducting peritoneal dialysis with a decreased total volume of dialysis fluid used and increased efficacy parameters such as ultrafiltration rate, urea clearance rate and dialysate volume as compared to conventional techniques. In the method of this invention, a fluid communication through the peritoneal membrane into the peritoneal cavity of a patient in need of peritoneal dialysis treatment is established. An initial volume of an aqueous peritoneal dialysis composition containing an osmotic agent is instilled into the peritoneal cavity through the fluid communication. The dialysis composition contains an amount of dissolved osmotic agent (i) that is insufficient to adequately dialyze the patient during a predetermined time period of dialysis treatment, but (ii) that is present at an osmolarity that is greater than the osmolarity of the body fluids in contact with the membrane, such that an osmolarity gradient is created across the membrane between the composition and the body fluids. A flux of water and solute enters the composition from the body fluids by means of that gradient. A further amount of dissolved osmotic agent is released into the instilled dialysis composition to form a modified dialysis composition.